Skip to content
View ARFarghli's full-sized avatar

Block or report ARFarghli

Block user

Prevent this user from interacting with your repositories and sending you notifications. Learn more about blocking users.

You must be logged in to block users.

Maximum 250 characters. Please don’t include any personal information such as legal names or email addresses. Markdown is supported. This note will only be visible to you.
Report abuse

Contact GitHub support about this user’s behavior. Learn more about reporting abuse.

Report abuse
ARFarghli/README.md

Hi, I'm Alaa. Nice to e-meet you!

LinkedIn Google Scholar ORCID

Computational biologist specializing in single-cell genomics, multi-omics integration, and cancer biology. I build and apply tools to understand the molecular underpinnings of disease at single-cell resolution.

My background is in cancer biology, with a focus on fibrolamellar carcinoma (FLC) and the tumor microenvironment. The analytical frameworks I've developed are broadly applicable across biomedical research, and I'm well equipped to bring these skills to new disease areas.

Currently seeking postdoc and industry positions in computational biology and single-cell genomics.

📍 Cornell University | 🔗 LinkedIn | 🎓 Google Scholar | 🔬 ORCID


Research focus

  • Single-nucleus and single-cell RNA-seq (snRNA-seq / scRNA-seq)
  • Chromatin accessibility profiling (scATAC-seq)
  • Multi-omics data integration
  • Cell-cell communication analysis
  • Tumor microenvironment characterization

Tools and languages

I code with: R Linux Git Shell Script Markdown

Bioinformatics: Seurat, ArchR, CellChat, Harmony, bioHPC / HPC clusters


Publications

Peer-reviewed

Farghli, A. R., Sherman, M. S., Shui, B., Stephanou, A., Pepe-Mooney, B. J., et al. (2026). Single-nucleus ATAC-seq analysis resolves chromatin and transcriptional features of fibrolamellar carcinoma. Scientific Reports.

Carter, J. A., Dickerson, L. K., Stephanou, A., et al. (2026). Overcoming CXCR4-mediated T-cell exclusion potentiates antitumor cytotoxicity in fibrolamellar carcinoma. Gastroenterology.

Nukaya, M., Carney, P. R., Cafferty, C., et al. (2025). CDK7 is a novel therapeutic target in fibrolamellar carcinoma. iScience.

DiPietro, E., Bharath, N., Karski, M., ..., Farghli, A. R., et al. (2025). Expression of DNAJB1-PRKACA oncogene suppresses the differentiation potential of liver progenitor organoids towards a hepatocyte lineage. Scientific Reports.

Ma, R. K., Tsai, P.-Y., Farghli, A. R., et al. (2024). DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma. PLoS Genetics, 20(3), e1011216.

Liu, S., Benito-Martin, A., Pelissier Vatter, F. A., ..., Farghli, A. R., et al. (2023). Breast adipose tissue-derived extracellular vesicles from obese women alter tumor cell metabolism. EMBO Reports, 24(12). (23 citations)

Pinned Loading

  1. SethupathyLab SethupathyLab Public

    RNA-seq, ChRO-seq, single-cell, and cancer biology pipelines developed during a research fellowship at the Sethupathy Lab (Cornell) — covering FLC tumor microenvironment analysis

    HTML 1

  2. ArchR_Tutorial ArchR_Tutorial Public

    Annotated guide for running ArchR single-cell ATAC-seq analysis on a bioHPC cluster, with troubleshooting tips and commentary

    HTML

  3. 2023_FLC_snRNA_Khasayer 2023_FLC_snRNA_Khasayer Public

    Single-nucleus RNA-seq analysis of FLC samples generated by the Khashayar lab, including QC, harmony integration, and CellChat analysis